NXTC - NextCure, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
+0.33 (+1.69%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close19.57
Bid19.88 x 800
Ask20.00 x 900
Day's Range19.45 - 20.80
52 Week Range15.08 - 22.75
Avg. Volume238,108
Market Cap451.439M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.07
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire17 days ago

    NextCure Announces Pricing of Initial Public Offering of Common Stock

    BELTSVILLE, Md., May 08, 2019 -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class.

  • Benzinga21 days ago

    IPO Outlook For The Week: Uber (And 11 Others)

    For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . The IPO dates below are expected but not confirmed. Milestone Pharmaceuticals Inc. (MIST) will issue 5 million shares between ...

  • We're sorry this is all we were able to find about this topic.